Heron Therapeutics, Inc. is a biotechnology firm dedicated to developing innovative therapeutic solutions for significant unmet patient needs. At the heart of its pipeline is the proprietary Biochronomer drug delivery system. This technology enables the sustained release of various short-acting pharmacological agents, maintaining therapeutic levels for several days to weeks following a single administration.